June 27, 2011
New drugs have started entering the domestic market for Alzheimer's dementia (AD) treatments, which has been monopolized for years by Eisai's Aricept (donepezil). In March, Janssen Pharma and Takeda Pharmaceutical launched Reminyl (galantamine), while Daiichi Sankyo's Memary (memantine) debuted earlier...read more